Page 11 - எங்களுக்கு அலுவலகம் ஆஃப் சிறப்பு ஆலோசனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sarah Silbiger/Getty Images In a stern letter, the U.S. Office of Special Counsel rebuked the Food and Drug Administration over four instances in which agency officials belatedly downgraded troubling findings at manufacturing plants and also urged the FDA to rethink its approach to oversight of inspections. The investigating agency cited, in particular, a high-profile episode involving a Merck (MRK)vaccine plant in North Carolina, where a whistleblower tipped off the FDA to numerous sanitary problems. An FDA inspector who subsequently visited the plant maintained the violations were serious enough to warrant action by both the FDA and the drug maker. But his recommendations were minimized by supervisors.

North carolinaUnited statesUs office of special counselDrug administrationSpecial counselWall streetSilicon valleyவடக்கு கரோலினாஒன்றுபட்டது மாநிலங்களில்எங்களுக்கு அலுவலகம் ஆஃப் சிறப்பு ஆலோசனைசிறப்பு ஆலோசனைசுவர் தெருசிலிக்கான் பள்ளத்தாக்கு